Get the Stockscreener App
6.06
2.54%
0.15
After Hours:
6.06
Artiva Biotherapeutics Inc Stock (ARTV) Forecast
The Artiva Biotherapeutics Inc (ARTV) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.893, representing a -19.26% decrease from the current price of $6.06. The highest analyst price target is $5.9046, and the lowest is $3.8814.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARTV Price Target
Average 5.9716
(-1.46% Downside)
Is Artiva Biotherapeutics Inc (ARTV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.82 | Buy |
| STOCH(9,6) | 21.42 | Neutral |
| STOCHRSI(14) | 40.77 | Neutral |
| MACD(12,26) | -0.8746 | Buy |
| ADX(14) | 54.34 | Sell |
| William %R | -86.45 | Buy |
| CCI(14) | -66.86 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.70
Sell
|
6.6265
Sell
|
| MA20 |
7.086
Sell
|
7.27
Sell
|
| MA50 |
9.4347
Sell
|
8.5006
Sell
|
| MA100 |
9.2834
Sell
|
8.7831
Sell
|
| MA200 |
7.972
Sell
|
7.85
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ARTV could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on ARTV, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.82 indicates that ARTV is oversold. This indicates that ARTV price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 21.42 indicates that ARTV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.77 indicates that ARTV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 54.34 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.86 indicates that ARTV is still oversold but not to an extreme extent.
Long-term ARTV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Artiva Biotherapeutics Inc financial reports and earnings history, Artiva Biotherapeutics Inc (ARTV) stock could reach $5.5626 by 2030, $26.66 by 2040 and $42.51 by 2050. See the projected annual prices until 2050 of the Artiva Biotherapeutics Inc stock below:
- Artiva Biotherapeutics Inc (ARTV) is expected to reach an average price of $15.19 in 2035, with a high prediction of $16.49 and a low estimate of $16.73. This indicates an $150.70% rise from the last recorded price of $6.06.
- Artiva Biotherapeutics Inc (ARTV) stock is projected to chart a bullish course in 2040, with an average price target of $26.79, representing an $342.07% surge from its current level. The forecast ranges from a conservative $25.26 to a sky-high $26.66.
- Our analysts predict Artiva Biotherapeutics Inc (ARTV) to jump 498.09% by 2045, soaring from $32.76 to an average price of $36.24, potentially reaching $34.71. While $32.76 is the low estimate, the potential upside is significant.
- Artiva Biotherapeutics Inc (ARTV) stock is expected to climb by 2050, reaching an average of $42.72, a $604.88% jump from its current level. However, a wide range of estimates exists, with high and low targets of $42.51 and $43.44, respectively, highlighting the market's uncertainty.
Artiva Biotherapeutics Inc Stock (ARTV) Year by Year Forecast
Artiva Biotherapeutics Inc Stock (ARTV) Price Forecast for 2026
The predicted value for Artiva Biotherapeutics Inc (ARTV) in 2026 is set at an average of $9.075. Estimates vary from a peak of $14.53 to a trough of $3.62, indicating an +49.75% surge from the present price of $6.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $5.7337 | $3.8814 | $5.9046 | -5.39% |
| December, 2026 | $8.2928 | $4.0505 | $9.7585 | +36.84% |
Artiva Biotherapeutics Inc Stock (ARTV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Artiva Biotherapeutics Inc (ARTV) is $5.9716, with a high forecast of $11.64 and a low forecast of $0.3058. This indicates an -1.46% decrease from the last price of $6.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.5419 | $5.8619 | $11.64 | +7.95% |
| February, 2027 | $7.571 | $4.0964 | $9.951 | +24.93% |
| March, 2027 | $5.1923 | $4.4932 | $8.3282 | -14.32% |
| April, 2027 | $5.3314 | $4.2746 | $6.1346 | -12.02% |
| May, 2027 | $1.3172 | $0.4795 | $6.2337 | -78.26% |
| June, 2027 | $0.2219 | $1.3181 | $1.0104 | -96.34% |
| July, 2027 | $2.049 | $0.3058 | $1.739 | -66.19% |
| August, 2027 | $2.5476 | $2.6676 | $2.6122 | -57.96% |
| September, 2027 | $2.8985 | $2.6254 | $2.6885 | -52.17% |
| October, 2027 | $3.1794 | $2.8917 | $2.7663 | -47.53% |
| November, 2027 | $2.2581 | $2.6081 | $3.1449 | -62.74% |
| December, 2027 | $1.799 | $1.7435 | $1.6312 | -70.31% |
Artiva Biotherapeutics Inc Stock (ARTV) Price Forecast for 2028
In 2028, Artiva Biotherapeutics Inc (ARTV) is projected to reach an average price of $5.4414, with a high projection of $10.86 and a low estimate of $0.0207. This indicates an -10.21% fall from the last price of $6.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.8976 | $1.4699 | $1.7267 | -68.69% |
| February, 2028 | $1.4085 | $1.5185 | $1.4453 | -76.76% |
| March, 2028 | $0.0994 | $0.1717 | $3.0461 | -98.36% |
| April, 2028 | $0.4203 | $0.9671 | $0.4003 | -93.06% |
| May, 2028 | $0.2211 | $0.0388 | $3.1366 | -96.35% |
| June, 2028 | $0.8002 | $0.0534 | $1.1579 | -86.80% |
| July, 2028 | $1.9516 | $0.0207 | $2.2015 | -67.80% |
| August, 2028 | $1.2307 | $0.9607 | $3.9303 | -79.69% |
| September, 2028 | $8.8598 | $1.313 | $9.5098 | +46.20% |
| October, 2028 | $6.2012 | $4.8743 | $10.86 | +2.33% |
| November, 2028 | $5.0503 | $3.078 | $6.6134 | -16.66% |
| December, 2028 | $6.2094 | $5.0148 | $7.0283 | +2.46% |
Artiva Biotherapeutics Inc Stock (ARTV) Price Forecast for 2029
The 2029 price forecast for Artiva Biotherapeutics Inc Stock (ARTV) is $4.6184 on average, with a high prediction of $9.003 and a low estimate of $0.2337. This represents an -23.79% decrease from the previous price of $6.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.9807 | $5.3939 | $8.7707 | +31.70% |
| February, 2029 | $8.0998 | $7.2676 | $9.003 | +33.66% |
| March, 2029 | $3.8789 | $3.7889 | $8.3292 | -35.99% |
| April, 2029 | $0.12 | $0.7625 | $4.3358 | -98.02% |
| May, 2029 | $0.0018 | $0.5409 | $0.2545 | -99.97% |
| June, 2029 | $1.5636 | $1.0382 | $0.7964 | -74.20% |
| July, 2029 | $3.7992 | $0.6455 | $5.9646 | -37.31% |
| August, 2029 | $0.4027 | $0.2337 | $4.0337 | -93.36% |
| September, 2029 | $1.8356 | $0.3455 | $4.4119 | -69.71% |
| October, 2029 | $0.6417 | $0.3554 | $2.2847 | -89.41% |
| November, 2029 | $4.6135 | $0.7272 | $3.0835 | -23.87% |
| December, 2029 | $6.1708 | $5.729 | $6.1708 | +1.83% |
Artiva Biotherapeutics Inc Stock (ARTV) Price Forecast for 2030
Artiva Biotherapeutics Inc Stock (ARTV) is expected to reach an average price of $5.777 in 2030, with a high forecast of $7.8598 and a low forecast of $3.6942. This signifies an -4.67% decrease from the last price of $6.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.9826 | $5.4217 | $5.5626 | +15.22% |
| February, 2030 | $7.7244 | $7.138 | $7.5944 | +27.46% |
| March, 2030 | $7.7062 | $7.5407 | $7.4053 | +27.16% |
| April, 2030 | $7.5834 | $7.6734 | $7.5925 | +25.14% |
| May, 2030 | $7.7752 | $7.8852 | $7.8598 | +28.30% |
| June, 2030 | $6.207 | $6.347 | $7.2707 | +2.43% |
| July, 2030 | $5.8343 | $6.3073 | $6.2634 | -3.73% |
| August, 2030 | $5.8461 | $5.9397 | $5.8706 | -3.53% |
| September, 2030 | $3.1733 | $4.4633 | $5.7715 | -47.64% |
| October, 2030 | $5.2751 | $4.5988 | $4.4651 | -12.95% |
| November, 2030 | $3.4869 | $4.2269 | $4.7539 | -42.46% |
| December, 2030 | $3.5842 | $3.6942 | $3.6633 | -40.86% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):